Filing Details

Accession Number:
0001179110-18-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-02 15:39:21
Reporting Period:
2017-12-28
Accepted Time:
2018-01-02 15:39:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509669 S Philip Low 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Chief Science Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-28 65,445 $3.06 354,050 No 4 M Direct
Common Stock Disposition 2017-12-28 50,511 $4.41 303,539 No 4 S Direct
Common Stock Disposition 2017-12-22 8,333 $0.00 184,985 No 5 G Indirect By spouse trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 5 G Indirect By spouse trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-12-28 65,445 $0.00 65,445 $3.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-02-12 No 4 M Direct
Footnotes
  1. Represents the sale of 50,511 shares in multiple transactions, ranging in price from $4.2700 to $4.5100 per share, resulting in a weighted average sale price per share of $4.4114. These shares were sold to cover the option exercise cost, taxes and fees in connection with the reporting person's exercise of stock options on December 28, 2017 as reported herein. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
  2. Represents a gift of 8,333 shares by Spouse Trust to a non-profit organization.
  3. The option is fully vested and immediately exercisable.